Take­da’s new deal with Kumquat; IL-2 biotech rais­es $55M

Plus, news about Neu­ro­crine Bio­sciences, Nx­era Phar­ma, Voy­ager Ther­a­peu­tics and Acor­da Ther­a­peu­tics:

Take­da inks pact with Kumquat: The San Diego biotech will get up to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.